2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

被引：73

作者：

Choi, Jong Han ^{[1
]}

Lee, Kyung Ae ^{[2
]}

Moon, Joon Ho ^{[3
]}

Chon, Suk ^{[4
]}

Kim, Dae Jung ^{[5
]}

Kim, Hyun Jin ^{[6
]}

Kim, Nan Hee ^{[7
]}

Seo, Ji A. ^{[7
]}

Kim, Mee Kyoung ^{[8
]}

Lim, Jeong Hyun ^{[9
]}

Song, YoonJu ^{[10
]}

Yang, Ye Seul ^{[11
]}

Kim, Jae Hyeon ^{[12
]}

Lee, You-Bin ^{[12
]}

Noh, Junghyun ^{[13
]}

Hur, Kyu Yeon ^{[12
]}

Park, Jong Suk ^{[14
]}

Rhee, Sang Youl ^{[4
]}

Kim, Hae Jin ^{[5
]}

Kim, Hyun Min ^{[15
]}

Ko, Jung Hae ^{[16
]}

Kim, Nam Hoon ^{[17
]}

Kim, Chong Hwa ^{[18
]}

Ahn, Jeeyun ^{[19
]}

Oh, Tae Jung ^{[3
]}

Kim, Soo-Kyung ^{[20
]}

Kim, Jaehyun ^{[21
]}

Han, Eugene ^{[22
]}

Jin, Sang-Man ^{[12
]}

Choi, Won Suk ^{[23
]}

Moon, Min Kyong ^{[24
]}

机构：

[1] Konkuk Univ, Med Ctr, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Seoul, South Korea

[2] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Dept Internal Med, Div Endocrinol & Metab,Med Sch, Jeonju, South Korea

[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea

[4] Kyung Hee Univ, Coll Med, Dept Endocrinol & Metab, Seoul, South Korea

[5] Ajou Univ, Ajou Univ Hosp, Dept Endocrinol & Metab, Sch Med, Suwon, South Korea

[6] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Coll Med, Daejeon, South Korea

[7] Korea Univ, Ansan Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Ansan, South Korea

[8] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Yeouido St Marys Hosp, Seoul, South Korea

[9] Seoul Natl Univ Hosp, Dept Food Serv & Nutr Care, Seoul, South Korea

[10] Catholic Univ Korea, Dept Food Sci & Nutr, Bucheon, South Korea

[11] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[12] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Endocrinol & Metab,Sch Med, Seoul, South Korea

[13] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Goyang, South Korea

[14] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea

[15] Chung Ang Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea

[16] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Busan, South Korea

[17] Korea Univ, Anam Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea

[18] Sejong Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Bucheon, South Korea

[19] Seoul Natl Univ, Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Ophthalmol, Coll Med, Seoul, South Korea

[20] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Seongnam, South Korea

[21] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Coll Med, Seongnam, South Korea

[22] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea

[23] Korea Univ, Ansan Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Ansan, South Korea

[24] Seoul Natl Univ, Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Internal Med, Coll Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea

来源：

DIABETES & METABOLISM JOURNAL | 2023年 / 47卷 / 05期

关键词：

Diabetes mellitus; Practice guideline; Prediabetic state; Republic of Korea; FATTY LIVER-DISEASE; FIXED-RATIO COMBINATION; INTENSIVE INSULIN THERAPY; PEPTIDE-1 RECEPTOR AGONIST; GLUCOSE-SENSING TECHNOLOGY; GLARGINE PLUS LIXISENATIDE; ONCE-DAILY LIXISENATIDE; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; BASAL INSULIN;

D O I：

10.4093/dmj.2023.0282

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In May 2023, the Committee of Clinical Practice Guidelines of the Korean Diabetes Association published the revised clinical practice guidelines for Korean adults with diabetes and prediabetes. We incorporated the latest clinical research findings through a comprehensive systematic literature review and applied them in a manner suitable for the Korean population. These guidelines are designed for all healthcare providers nationwide, including physicians, diabetes experts, and certified diabetes educators who manage patients with diabetes or individuals at risk of developing diabetes. Based on recent changes in international guidelines and the results of a Korean epidemiological study, the recommended age for diabetes screening has been lowered. In collaboration with the relevant Korean medical societies, recently revised guidelines for managing hypertension and dyslipidemia in patients with diabetes have been incorporated into this guideline. An abridgment containing practical information on patient education and systematic management in the clinic was published separately.

引用

页码：575 / 594

页数：20

共 141 条

[71] Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022 [J].

Lee, Kyung Ae ;

Kim, Dae Jung ;

Han, Kyungdo ;

Chon, Suk ;

Moon, Min Kyong .

DIABETES & METABOLISM JOURNAL, 2022, 46 (06) :819-826

[72] Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness [J].

Lee, Yong-ho ;

Kim, Jae Hyeon ;

Kim, So Ra ;

Jin, Heung Yong ;

Rhee, Eun-Jung ;

Cho, Young Min ;

Lee, Byung-Wan .

JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (01) :60-69

[73] Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis [J].

Lee, Yung ;

Doumouras, Aristithes G. ;

Yu, James ;

Brar, Karanbir ;

Banfield, Laura ;

Gmora, Scott ;

Anvari, Mehran ;

Hong, Dennis .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) :1040-+

[74] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].

LEWIS, EJ ;

HUNSICKER, LG ;

BAIN, RP ;

ROHDE, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462

[75] Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis [J].

Li, Yan ;

Liu, Lei ;

Wang, Bin ;

Wang, Jun ;

Chen, Dongfeng .

BIOMEDICAL REPORTS, 2013, 1 (01) :57-64

[76] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Lindholm, LH ;

Ibsen, H ;

Dahlöf, B ;

Devereux, RB ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Aurup, P ;

Edelman, J ;

Snapinn, S .

LANCET, 2002, 359 (9311) :1004-1010

[77] Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes The DUAL V Randomized Clinical Trial [J].

Lingvay, Ildiko ;

Perez Manghi, Federico ;

Garcia-Hernandez, Pedro ;

Norwood, Paul ;

Lehmann, Lucine ;

Tarp-Johansen, Mads Jeppe ;

Buse, John B. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (09) :898-907

[78] The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial [J].

Linjawi, Sultan ;

Bode, Bruce W. ;

Chaykin, Louis B. ;

Courreges, Jean-Pierre ;

Handelsman, Yehuda ;

Lehmann, Lucine M. ;

Mishra, Abhishek ;

Simpson, Richard W. .

DIABETES THERAPY, 2017, 8 (01) :101-114

[79] A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses [J].

Maloney, Alan ;

Rosenstock, Julio ;

Fonseca, Vivian .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (05) :1213-1223

[80] Liraglutide and Renal Outcomes in Type 2 Diabetes [J].

Mann, Johannes F. E. ;

Orsted, David D. ;

Brown-Frandsen, Kirstine ;

Marso, Steven P. ;

Poulter, Neil R. ;

Rasmussen, Soren ;

Tornoe, Karen ;

Zinman, Bernard ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :839-848

← 3 4 5 6 7 8 9 10 11 12 →